A Study of AMDX-2011P in Participants With Primary Open Angle Glaucoma

Status unconfirmed · Phase 2

Conditions studied: Primary Open Angle Glaucoma

In brief

The purpose of this research study is to assess the ability of AMDX- 2011P to identify amyloid deposits in the retina of participants with Primary Open Angle Glaucoma (POAG).

Key facts

Study ID

NCT06223048

Run by

Amydis Inc.

People needed

50

Starts

2023-12-07

Expected to finish

2025-02-01

Last updated by the study team

2024-07-30

Who can join

Age: 22 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of primary open angle glaucoma in both eyes
• Able to fixate
• Glaucomatous optic nerve damage in both eyes, as determined by an investigator as part of an eye exam

You may not qualify if…

• Participants unable to read or write
• Ocular media is not sufficiently clear to obtain acceptable quality images
• Participants with presence of any ocular pathology other than glaucoma in the study eye (cataracts are acceptable)

Where it is running

• Associated Retina Consultants — Phoenix, Arizona, United States (enrolling)
• Global Research Management — Glendale, California, United States (enrolling)
• Eye Research Foundation — Newport Beach, California, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.